Quantitative enzyme immunoassay and semiquantitative immunohistochemistry of oestrogen and progesterone receptors in endometriotic tissue and endometrium.

Por Bergqvist, A, Fernö, M, Skoog, L
Publicado em 1997

2'-Deoxy-2'-azidocytidine inhibits the initiation of polyoma DNA synthesis.

Por Bjursell, G, Skoog, L, Thelander, L, Söderman, G
Publicado em 1977

Loss of heterozygosity in human ductal breast tumors indicates a recessive mutation on chromosome 13.

Por Lundberg, C, Skoog, L, Cavenee, W K, Nordenskjöld, M
Publicado em 1987

Content of low density lipoprotein receptors in breast cancer tissue related to survival of patients.

Por Rudling, M J, Ståhle, L, Peterson, C O, Skoog, L
Publicado em 1986

Receptors for EGF and oestradiol and thymidinekinase activity in different histological subgroups of human mammary carcinomas.

Por Skoog, L., Macias, A., Azavedo, E., Lombardero, J., Klintenberg, C.
Publicado em 1986

Expression of Akt kinases related to ErbB2 and results of adjuvant therapy of breast cancer

Por Stal, O, Akerberg, L, Nordenskjold, B, Olsson, B, Rutqvist, LE, Skoog, L
Publicado em 2000

Oestrogen receptor co-activator AIB1 is a marker of tamoxifen benefit in postmenopausal breast cancer

Por Weiner, M., Skoog, L., Fornander, T., Nordenskjöld, B., Sgroi, D. C., Stål, O.
Publicado em 2013

Glucocorticoid receptor concentrations and terminal transferase activity as indicators of prognosis in acute non-lymphocytic leukaemia.

Por Skoog, L, Nordenskjöld, B, Ost, A, Andersson, B, Hast, R, Giannoulis, N, Humla, S, Hägerström, T, Reizenstein, P
Publicado em 1981

Prognostic significance of terminal transferase activity and glucocorticoid receptor levels in acute myeloid leukemia.

Por Skoog, L., Ost, A., Biberfeld, P., Christensson, B., Hast, R., Lagerlöf, B., Nordenskjöld, B., Reizenstein, P.
Publicado em 1984

Screening for TP53 mutations in patients and tumours from 109 Swedish breast cancer families.

Por Zelada-Hedman, M., Børresen-Dale, A. L., Claro, A., Chen, J., Skoog, L., Lindblom, A.
Publicado em 1997

High-resolution representational oligonucleotide microarray analysis and fluorescence in situ hybridization analysis of aneuploid and diploid breast tumors

Por Hicks, J, Grubor, V, Navin, N, Lundin, P, Månér, S, Hägerström, T, Skoog, L, Wigler, M, Zetterberg, A
Publicado no Breast Cancer Res (2005)

S-phase fraction and survival benefit from adjuvant chemotherapy or radiotherapy of breast cancer.

Por Stål, O., Skoog, L., Rutqvist, L. E., Carstensen, J. M., Wingren, S., Sullivan, S., Andersson, A. C., Dufmats, M., Nordenskjöld, B.
Publicado em 1994

Prognostic utility of HOXB13 : IL17BR and molecular grade index in early-stage breast cancer patients from the Stockholm trial

Por Jerevall, P-L, Ma, X-J, Li, H, Salunga, R, Kesty, N C, Erlander, M G, Sgroi, D C, Holmlund, B, Skoog, L, Fornander, T, Nordenskjöld, B, Stål, O
Publicado em 2011

An expression signature at diagnosis to estimate prostate cancer patients' overall survival

Por Peng, Z, Skoog, L, Hellborg, H, Jonstam, G, Wingmo, I-L, Hjälm-Eriksson, M, Harmenberg, U, Cedermark, G C, Andersson, K, Ährlund-Richter, L, Pramana, S, Pawitan, Y, Nistér, M, Nilsson, S, Li, C
Publicado em 2014